Healthcare Outcomes Performance Company10.05.20
Healthcare Outcomes Performance Company (HOPCo) has announced the acquisition of Stryker Performance Solutions’ (SPS) BPCI-A value-based care convener business and segments of SPS’ health system orthopedic service line analytics subscription business. This acquisition now makes HOPCo one of the largest conveners of MSK bundle payment programs and the largest manager of orthopedic service lines in the country, with over 100 hospital and physician practice customers. In this transaction, HOPCo will acquire Episode Performance Manager—SPS’ leading outcomes management software—as well as assume Stryker’s interest in a clinically integrated network based in Buffalo, NY. HOPCo will also be licensing RecoveryCoach and the orthopedic Hospital Reported Outcomes analytics tools to provide excellent service and additional tools to customers.
HOPCo is a leading provider of practice and outcomes management, value-based health care solutions and care coordination for musculoskeletal practices, health systems and clinically integrated care networks. HOPCo’s affiliated practice networks and health system partners successfully participate in population health, bundled payments, and other unique value-based care programs utilizing HOPCo’s proprietary technology platforms and clinical care pathways. The SPS convener and orthopedic analytics subscription business lines will be added to HOPCo’s broader suite of tools focused on population health and will further accelerate performance by leveraging the data collected and efficiencies developed by HOPCo for over a decade.
“HOPCo has been at the forefront of delivering successful advanced alternative payment models since 2005 and has a proven track record of results of partnering with hospitals, payors and physician groups to deploy programs that improve patient outcomes while bending the cost curve to improve the financial performance of all stakeholders. With this acquisition, HOPCo will expand its population health and musculoskeletal management programs to existing SPS and HOPCo customers, as well as new customers throughout the U.S.,” said CEO of HOPCo, Dr. David Jacofsky. “With HOPCo’s robust array of tools and analytics, and the addition of these assets developed by SPS, we can better help align stakeholders to drive their market transformation as they become more operationally efficient and lead the move toward value-based care.”
In order to ensure the continuity of services for existing customers, several SPS employees will join HOPCo’s Health System and Value-Based Care Management division as part of the acquisition.
“We expect the transition of SPS customers to the HOPCo platform to be virtually seamless and we see nothing but additional value for existing customers,” said DeLyle Manwaring, who leads this division at HOPCo. “In the coming months, customers will have the ability to integrate with our custom suite of existing IT tools and analytics in order to help them move to true population health for musculoskeletal care.”
“We’re confident that this decision sets our customers up for continued success. Stryker will continue to focus on the expansion of its Mako Program Analytics offering and execute on the company’s future vision with SmartRobotics. Our data analytics focus on Mako will complement the services HOPCo will provide. Our aim is to help facilities realize the full potential of Mako SmartRobotics and provide solutions to enable better decision making as well as strong patient engagement,” said Brian McCrone, vice president, Stryker’s Performance Solutions.
HOPCo is a leading provider of practice and outcomes management, value-based health care solutions and care coordination for musculoskeletal practices, health systems and clinically integrated care networks. HOPCo’s affiliated practice networks and health system partners successfully participate in population health, bundled payments, and other unique value-based care programs utilizing HOPCo’s proprietary technology platforms and clinical care pathways. The SPS convener and orthopedic analytics subscription business lines will be added to HOPCo’s broader suite of tools focused on population health and will further accelerate performance by leveraging the data collected and efficiencies developed by HOPCo for over a decade.
“HOPCo has been at the forefront of delivering successful advanced alternative payment models since 2005 and has a proven track record of results of partnering with hospitals, payors and physician groups to deploy programs that improve patient outcomes while bending the cost curve to improve the financial performance of all stakeholders. With this acquisition, HOPCo will expand its population health and musculoskeletal management programs to existing SPS and HOPCo customers, as well as new customers throughout the U.S.,” said CEO of HOPCo, Dr. David Jacofsky. “With HOPCo’s robust array of tools and analytics, and the addition of these assets developed by SPS, we can better help align stakeholders to drive their market transformation as they become more operationally efficient and lead the move toward value-based care.”
In order to ensure the continuity of services for existing customers, several SPS employees will join HOPCo’s Health System and Value-Based Care Management division as part of the acquisition.
“We expect the transition of SPS customers to the HOPCo platform to be virtually seamless and we see nothing but additional value for existing customers,” said DeLyle Manwaring, who leads this division at HOPCo. “In the coming months, customers will have the ability to integrate with our custom suite of existing IT tools and analytics in order to help them move to true population health for musculoskeletal care.”
“We’re confident that this decision sets our customers up for continued success. Stryker will continue to focus on the expansion of its Mako Program Analytics offering and execute on the company’s future vision with SmartRobotics. Our data analytics focus on Mako will complement the services HOPCo will provide. Our aim is to help facilities realize the full potential of Mako SmartRobotics and provide solutions to enable better decision making as well as strong patient engagement,” said Brian McCrone, vice president, Stryker’s Performance Solutions.